Clinical Trials in Newberg, United States
Locations / Newberg, United States
Delta Trials lists 86 clinical trials conducted in Newberg, United States, making it a notable site of clinical research activity. These trials addressing 613 medical conditions, reflecting the scope and diversity of clinical research in this location. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Newberg research landscape.
86
Total Trials
613
Conditions
0
Terminated since 2020
Browse by condition (613 total)
- Stage iiib lung cancer ajcc v8 6 trialsAll Stage iiib lung cancer ajcc v8 trials
- Stage iiia lung cancer ajcc v8 5 trialsAll Stage iiia lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Metastatic malignant solid neoplasm 4 trialsAll Metastatic malignant solid neoplasm trials
- Stage ii lung cancer ajcc v8 4 trialsAll Stage ii lung cancer ajcc v8 trials
- All Recurrent primary peritoneal carcinoma trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- All Clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- Lung non-small cell carcinoma 3 trialsAll Lung non-small cell carcinoma trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- All Clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- Neuroendocrine tumor g2 3 trialsAll Neuroendocrine tumor g2 trials
- Sarcomatoid renal cell carcinoma 3 trialsAll Sarcomatoid renal cell carcinoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stage iv renal cell cancer ajcc v8 3 trialsAll Stage iv renal cell cancer ajcc v8 trials